Fig. 3From: An updated PREDICT breast cancer prognostication and treatment benefit prediction model with independent validationAge-specific HR for non-breast cancer mortality derived from the model development data. ER-negative is indicated by red lines; ER-positive is indicated by blue lines. ER Oestrogen receptorBack to article page